Key result
LVAD patients 3 months post-implantation exhibited significantly lower chronotropic reserve (57% vs 90%, P<0.001) and heart rate recovery (14 vs 28 bpm, P<0.01) compared to healthy controls.
Why the study?
Does LVAD implantation improve chronotropic response and heart rate recovery in patients with chronic heart failure compared to healthy controls and advanced HF patients?
Observational (n=28)
Does LVAD implantation improve chronotropic response and heart rate recovery in patients with chronic heart failure compared to healthy controls and advanced HF patients?
Absolute Event Rate: 57% vs 90%
p-value: p=<0.001
Patients with LVADs continue to exhibit impaired chronotropic reserve and abnormal heart rate recovery early after implantation, similar to advanced heart failure patients, indicating persistent cardiac autonomic abnormalities.
Impaired chronotropic reserve and HR recovery persist 3 months post-LVAD; leaves open autonomic recovery timelines and outcome associations.
BACKGROUND: Chronotropic response to exercise and heart rate recovery immediately after exercise (HRR(1) ) are valid prognostic markers in patients with chronic heart failure (CHF). The aim of this study was to evaluate heart rate profile during and after exercise in CHF patients early after left ventricular assist device (LVAD) implantation. METHODS: We enrolled seven stable consecutive CHF patients (five males, mean age: 45 ± 16 years) after 1 month of LVAD (HeartMate II; Thoratec Corp, Pleasanton, CA, USA) implantation, seven healthy subjects, and 14 patients with advanced HF (HF control group) who performed an incremental symptom-limited cardiopulmonary exercise testing (CPET). CHF patients performed CPET at 1 and 3 months after LVAD. HRR(1) was defined as the HR difference from peak to 1 minute after exercise and chronotropic response to exercise as the chronotropic reserve ([CR, %]=[peak HR-resting HR/220-age-resting HR]× 100). RESULTS: LVAD patients 3 months after implantation had a significantly different HR profile during exercise compared to healthy controls, with significantly lower CR (57 ± 31 vs 90 ± 14, %, P < 0.001) and HRR(1) (14 ± 6 vs 28 ± 8, bpm, P < 0.01). HR profile during exercise did not significantly change 1 and 3 months after LVAD implantation. There was no statistical difference compared to HF control group and LVAD group regarding cardiopulmonary parameters. CONCLUSIONS: LVAD patients present an impaired CR and an abnormal HRR(1) after implantation, indicating significant cardiac autonomic abnormalities. These alterations seem to remain unaltered 3 months after LVAD implantation.
No takes yet. Share an insight, caveat, or question.
Dimopoulos et al. (2011) conducted an observational in Chronic heart failure (n=28). Left ventricular assist device (LVAD) implantation vs. Healthy subjects and advanced heart failure patients was evaluated on Chronotropic reserve (CR, %) (p=<0.001). LVAD patients 3 months post-implantation exhibited significantly lower chronotropic reserve (57% vs 90%, P<0.001) and heart rate recovery (14 vs 28 bpm, P<0.01) compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: